IP Library Patent Application 14523837
Patent Application
App. No. 14/523,837

Strigolactone Compositions And Uses Thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/523,837
Abstract

Disclosed herein plant propagation materials, methods of manufacturing, formulations and uses thereof. The plant propagation materials disclosed herein may comprise a strigolactone obtained by a biosynthetic process. The plant propagation material may comprise a chemical mimic of a strigolactone. The strigolactone may be 5-deoxystrigol. Methods of manufacturing the plant propagation materials may comprise a chemical process. Alternatively, methods of manufacturing the plant propagation material may comprise a biosynthetic process. The methods may comprise use of one or more polynucleotides. The polynucleotides may encode a metabolite. The polynucleotides may comprise one or more genes encoding one or more components of a strigolactone pathway.

Claims (54)

1 . A compound of Formula (I), a salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer thereof:

wherein:

a, c are each independently 0, 1, or 2;

b is 1 or 2;

each A is independently O, or S;

each E is independently O, S, or —NR 18 ;

each G is independently C;

R 5 , R 6 , R 11 , R 12 , R 14 , R 15 and R 17 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ;

R 2 , R 3 , R 7 , R 8 , R 9 , and R 10 are each independently H, alkyl, haloalkyl, amino, halo, —OR 18 or a lone electron pair;

R 1 and R 16 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ; or R 1 and R 16 together form a direct bond to provide a double bond;

R 4 and R 13 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ; or R 4 and R 13 together form a direct bond to provide a double bond;

each R 18 is independently H, alkyl, haloalkyl, aryl, heteroaryl, —C(O)R 19 or

and

each R 19 is independently H, alkyl, haloalkyl, aryl, or heteroaryl.

2 . A compound of Formula (II), a salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer thereof:

wherein:

a, c are each independently 0, 1, or 2;

b is 1 or 2:

each A is independently O, or S;

each E is independently O, S, or —NR 18 ;

each G is independently C;

R 5 , R 6 , R 11 , R 12 , R 14 , R 15 and R 17 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ;

R 2 , R 3 , R 7 , R 8 , R 9 , and R 10 are each independently H, alkyl, haloalkyl, amino, halo, —OR 18 or a lone electron pair;

R 1 and R 16 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ; or R 1 and R 16 together form a direct bond to provide a double bond;

R 4 and R 13 are each independently H, alkyl, haloalkyl, amino, halo, or —OR 18 ; or R 4 and R 13 together form a direct bond to provide a double bond;

each R 18 is independently H, alkyl, haloalkyl, aryl, heteroaryl, —C(O)R 19 or

and

each R 19 is independently H, alkyl, haloalkyl, aryl, or heteroaryl.

3 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein a is 1, b is 2, c is 0.

4 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein each A is independently O.

5 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein each E is independently O.

6 . (canceled)

7 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein R 2 , R 3 , R 4 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , and R 16 are each independently H.

8 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein R 1 , R 5 , R 6 , R 13 , and R 17 are each independently alkyl.

9 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 8 , wherein R 1 , R 5 , R 6 , R 13 , and R 17 are each independently methyl.

10 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 9 , having the structure of Formula (III):

11 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 9 , having the structure of Formula (IV):

12 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer has a diastereomeric excess of at least about 50%.

13 . A formulation comprising the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 .

14 - 21 . (canceled)

22 . A method comprising contacting a plant with the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 or the formulation of claim 13 .

23 - 51 . (canceled)

52 . A method of making a formulation comprising forming the formulation with the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 .

53 - 54 . (canceled)

55 . A method of producing the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 comprising alkylating

or a salt thereof, wherein R 17 is H, alkyl, halo, or haloalkyl and X is Cl, Br, or L.

56 - 67 . (canceled)

68 . An engineered cell comprising a plurality of polynucleotides, wherein (i) the plurality of polynucleotides encode one or more metabolites; and/or (ii) the plurality of polynucleotides comprise one or more heterologous genes selected from a group comprising crtE, crtB, crtI, D27, CCD7, CCD8, and MAXI.

69 - 76 . (canceled)

77 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 , wherein in the moiety:

the stereocenter * is selected from the group consisting of: (S), (R), racemic, and a non-racemic mixture of (R) and (S).

78 . The compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 10 or 11 , wherein in the moiety:

the stereocenter * is selected from the group consisting of: (S), (R), racemic, and a non-racemic mixture of (R) and (S).

79 . A plant, food, or seed comprising the compound, salt, solvate, polymorph, diastereoisomer, stereoisomer, or isomer of claim 1 or the formulation of claim 13 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2015
From: DAVIDSON, ERIC A.; BAYER, TRAVIS S.; WINDRAM, OLIVER; HLEBA, YONEK
To: ASILOMAR BIO, INC.
Reel/Frame 035809/0409 →